Can We Afford the Future of Medicine? The Promise and Price of Cell and Gene Therapies

icon mic

September 21, 2026

The promise of cell and gene therapies is big. They have the ability to address the underlying genetic causes of disease, offering new possibilities for people with serious and previously difficult-to-treat conditions. But as cell and gene therapies move beyond just treating rare diseases to also address conditions such as high cholesterol, the market is being shaped by new questions about access and value. The evidence base for existing therapies also continues to evolve, particularly as researchers assess long-term outcomes for treatments that are often approved based on small patient datasets.

Sarah Emond, President and CEO of the Institute for Clinical and Economic Review (ICER), returns to the Business Group on Health podcast to discuss what has changed in the cell and gene therapy market. The conversation explores evolving evidence, how therapies are priced and paid for, provider capacity, regulatory developments, and the long-term durability of treatment outcomes.

As the number of people who become eligible for cell and gene therapies grows, employers face the challenge of connecting employees and their families to potentially life-changing therapies, while also assessing value and managing financial risk.

Tune in for practical insights into new developments, emerging payment options and how stakeholders across the healthcare ecosystem can work together to balance innovation, access and affordability.

SPEAKERS

Sarah Emond | President and CEO, Institute for Clinical and Economic Review (ICER)

Ellen Kelsay | President and CEO, Business Group on Health

Download Transcript 

Duration 33 min

Subscribe To The Podcast

All Podcasts

Showing items 51-60 of 132
Apr 08, 2024
What Does It Mean to Be a Grief-Informed Workplace...
Learn about strategies to build a grief-informed workplace from Meghan Riordan Jarvis, clinical psychotherapist and grief...
Read more
Mar 18, 2024
Managing Equity, Fostering Innovation in Rural...
Alan Morgan joins the podcast to shed light on health care challenges facing rural communities.
Read more
Mar 04, 2024
Designing the "Carrot” in Incentive Programs...
How and why do incentives shape human behavior? Uri Gneezy joins the podcast to share what the design of incentives signal and how...
Read more
Feb 19, 2024
The Power of Transparency to Transform Patient...
Listen to our podcast with The Leapfrog Group’s Leah Binder to learn about how transparent hospital data can help employers drive...
Read more
Feb 05, 2024
Mindful Medicine: Exploring the Treatment...
Andrew Penn, a psychiatric nurse practitioner, joins the podcast to discuss the recent developments in psychedelic-assisted...
Read more
Jan 22, 2024
Half of the Equation: Exploring Modern Issues in...
Listen to our interview with leading clinician and researcher in male reproductive health, Dr. Joseph Alukal, who helps expand our...
Read more
Jan 08, 2024
Exploring the Landscape of Obesity Treatment
Listen to this podcast with Dr. Scott Kahan to learn about how the obesity medicine landscape has evolved and the need for a...
Read more
Dec 11, 2023
How "Long COVID Robs People of Who They...
Dr. Panagis Galiatsatos, a physician treating patients with Long COVID, joins us to discuss the clinical research and treatment of...
Read more
Nov 27, 2023
Cell and Gene Therapy: Tapping into the Potential...
Hear from Sarah Emond, ICER’s President-Elect, about the potential of cell and gene therapies to transform the treatment landscape...
Read more
Nov 14, 2023
Winding the Clock for Better Health: The Power of...
Listen to this interview with Professor Russell Foster to learn how we can follow our bodies’ natural circadian rhythm to achieve...
Read more
Showing items 51-60 of 132